Rosenbloom, D.I.S.; Dudášová, J.; Davis, C.; Railkar, R.A.; Mehrotra, N.; Sachs, J.R.
Replicate Testing of Clinical Endpoints Can Prevent No-Go Decisions for Beneficial Vaccines. Vaccines 2023, 11, 1501.
https://doi.org/10.3390/vaccines11091501
AMA Style
Rosenbloom DIS, Dudášová J, Davis C, Railkar RA, Mehrotra N, Sachs JR.
Replicate Testing of Clinical Endpoints Can Prevent No-Go Decisions for Beneficial Vaccines. Vaccines. 2023; 11(9):1501.
https://doi.org/10.3390/vaccines11091501
Chicago/Turabian Style
Rosenbloom, Daniel I. S., Julie Dudášová, Casey Davis, Radha A. Railkar, Nitin Mehrotra, and Jeffrey R. Sachs.
2023. "Replicate Testing of Clinical Endpoints Can Prevent No-Go Decisions for Beneficial Vaccines" Vaccines 11, no. 9: 1501.
https://doi.org/10.3390/vaccines11091501
APA Style
Rosenbloom, D. I. S., Dudášová, J., Davis, C., Railkar, R. A., Mehrotra, N., & Sachs, J. R.
(2023). Replicate Testing of Clinical Endpoints Can Prevent No-Go Decisions for Beneficial Vaccines. Vaccines, 11(9), 1501.
https://doi.org/10.3390/vaccines11091501